ATE60771T1 - 2-SUBSTITUTED-E-CONDENSED(1,5-C>-PYRIMIDINE , PHARMACEUTICAL PREPARATIONS AND THEIR USE. - Google Patents

2-SUBSTITUTED-E-CONDENSED(1,5-C>-PYRIMIDINE , PHARMACEUTICAL PREPARATIONS AND THEIR USE.

Info

Publication number
ATE60771T1
ATE60771T1 AT86810421T AT86810421T ATE60771T1 AT E60771 T1 ATE60771 T1 AT E60771T1 AT 86810421 T AT86810421 T AT 86810421T AT 86810421 T AT86810421 T AT 86810421T AT E60771 T1 ATE60771 T1 AT E60771T1
Authority
AT
Austria
Prior art keywords
pyrimidine
condensed
substituted
pharmaceutical preparations
preparations
Prior art date
Application number
AT86810421T
Other languages
German (de)
Inventor
John E Dr Francis
Karl O Gelotte
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority claimed from EP86810421A external-priority patent/EP0217748B1/en
Application granted granted Critical
Publication of ATE60771T1 publication Critical patent/ATE60771T1/en

Links

AT86810421T 1985-09-30 1986-09-25 2-SUBSTITUTED-E-CONDENSED(1,5-C>-PYRIMIDINE , PHARMACEUTICAL PREPARATIONS AND THEIR USE. ATE60771T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78223485A 1985-09-30 1985-09-30
US84198686A 1986-03-20 1986-03-20
EP86810421A EP0217748B1 (en) 1985-09-30 1986-09-25 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof

Publications (1)

Publication Number Publication Date
ATE60771T1 true ATE60771T1 (en) 1991-02-15

Family

ID=27229536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86810421T ATE60771T1 (en) 1985-09-30 1986-09-25 2-SUBSTITUTED-E-CONDENSED(1,5-C>-PYRIMIDINE , PHARMACEUTICAL PREPARATIONS AND THEIR USE.

Country Status (1)

Country Link
AT (1) ATE60771T1 (en)

Similar Documents

Publication Publication Date Title
DE3582399D1 (en) PURINE DERIVATIVES AND THEIR PHARMACEUTICAL USE.
DE3677445D1 (en) 2-SUBSTITUTED-E-CONDENSED (1,5-C) -PYRIMIDINE, PHARMACEUTICAL PREPARATIONS AND THEIR USE.
DE3580616D1 (en) MITOMYCINE DERIVATIVES, THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
NL300038I2 (en) Thiazolidinedione derivatives and their preparation and use.
DE3685170D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING HISTAMINE DERIVATIVES.
DE3885534D1 (en) Arylphosphorus derivatives, their preparation and use.
DE59808804D1 (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations containing them
DE69131714D1 (en) CEPHALOSPORINE AND ITS HOMOLOGOS, PREPARATIONS AND PHARMACEUTICAL PREPARATIONS
DE3750432D1 (en) IL-1 alpha derivatives and drugs.
DE3869167D1 (en) PHENYLTRIAZOLE DERIVATIVES AND INSECTICIDE.
NL970029I1 (en) Benzimidazole derivatives, preparation and therapeutic application.
DE3879811D1 (en) PHARMACEUTICAL COMPOSITION AND THEIR USE.
DE69027170D1 (en) Uracilder derivatives, their preparation and their use
ATE449786T1 (en) IMIDAZOLIDINE DERIVATIVES, THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3682083D1 (en) PHARMACEUTICAL COMPOSITIONS.
DE3682960D1 (en) PHARMACEUTICAL PREPARATIONS.
DE3576118D1 (en) PHARMACEUTICAL PREPARATIONS.
DE3674040D1 (en) PHARMACEUTICAL COMPOSITIONS.
DE3783751D1 (en) GLYZIRRHETINIC ACID DERIVATIVES AND THEIR USE.
DE3681856D1 (en) PHARMACEUTICAL 2-OXOPYRROLIDINE COMPOUNDS, THEIR SALTS AND THEIR PRODUCTION.
DE68919259D1 (en) N-phenylimides, their preparation and use.
FI863159A7 (en) Heterocyclocarbonyl and acetylthiazolones used as cardiac drugs.
DE3689036D1 (en) Lankacidine derivatives and their preparation.
DK388986A (en) 7-OXO-4-THIA-1-AZABICYCLO (3.2.0) HEPT-2-EN-DERIVATIVES, THEIR PREPARATION AND USE
ATE60771T1 (en) 2-SUBSTITUTED-E-CONDENSED(1,5-C>-PYRIMIDINE , PHARMACEUTICAL PREPARATIONS AND THEIR USE.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee